Fund companies intensively investigate the pharmaceutical industry, and the number of these four pharmaceutical companies exceeds 50

[pharmaceutical network industry trends] according to industry statistics, between February 3 and February 13, 716 fund companies have investigated 82 listed companies, with 1374 times From the perspective of industry classification, the pharmaceutical industry is a hot industry of fund research, during which 342 times of fund research were conducted Among them, Meirui medical, Boya biology, Weining health and entrepreneurial Huikang, four pharmaceutical listed companies, were investigated by more than 50 fund companies It is worth mentioning that since February, the share prices of these four pharmaceutical companies have all increased by more than 20%, among which the share prices of Weining health have increased by more than 30% Next, the author will give a brief introduction to these pharmaceutical enterprises The number of fund companies investigated by Mindray medical: according to 96 companies, Mindray medical is a company engaged in the production and sales of medical devices Its main products include life information and support equipment such as ventilator, defibrillator, anesthesia machine, etc.; in vitro dispute equipment such as biochemical analyzer, blood cell analyzer, etc.; medical imaging equipment such as color Doppler ultrasound, etc It is understood that Mindray medical has attracted the attention of a large number of fund companies after the Spring Festival In 11 days, 96 fund companies have started the research mode In terms of the content of the investigation, the main concerns of the fund company are: whether the overseas business of Mindray medical is affected by the epidemic situation, the reasons for the company's large number of products winning the bid in huoshenshan project, and the situation of the company's resumption of production and work, etc Number of fund companies surveyed by Boya biology: 64 Boya biology is a designated unit specializing in blood products production In 11 days, a total of 64 fund companies launched a research model for Boya biology In terms of the content of the investigation, the main concerns of the fund companies are: the impact of the epidemic on blood products, when the company will resume plasma collection, the progress of the company's resumption of production and work, etc Ge Chen, manager of Boshi healthcare fund, said that from the perspective of the industry, the impact of the epidemic in different industries is quite different The pharmaceutical industry is directly affected by the negative impact of the epidemic, showing a certain degree of resilience, and is focused by the market Some sub sectors even rose against the trend Novel coronavirus has been undergoing intense scientific and clinical research in the medical field It has made gratifying progress The pharmaceutical industry is also a long-term steady growth industry Number of fund companies investigated by Weining health: 56 data show that Weining health is a listed company focusing on medical and health information, mainly providing medical and health information solutions In 11 days, a total of 56 fund companies started the research mode for Weining health The research contents include the differences between the company and some medical information companies that launched quick consultation during the epidemic, and whether they will promote the development of online business of the hospital Number of fund companies surveyed by venture Huikang: 53 venture Huikang mainly engaged in the construction, R & D and service innovation of medical and health informatization Within 11 days, 53 fund companies were investigated, including whether the epidemic will affect the company's first quarter performance, the company's market situation in Hubei, whether the hospital medical treatment will have new demand after the epidemic, the current situation of the public health information emergency system, and the impact of the epidemic on the company's business.